[Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].

@article{Song2014ClinicalOO,
  title={[Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus].},
  author={Tiemei Song and Guanghua Chen and X. Zhang and Y. Xu and J. Chen and Y. Wang and Linlin Ye and J. Xu and D. Wu and Jingcheng Miao},
  journal={Zhonghua yi xue za zhi},
  year={2014},
  volume={94 40},
  pages={
          3135-9
        }
}
  • Tiemei Song, Guanghua Chen, +7 authors Jingcheng Miao
  • Published 2014
  • Medicine
  • Zhonghua yi xue za zhi
  • OBJECTIVE To evaluate the impact of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) co-activation on the prognosis of allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients. METHODS We retrospectively analyzed 330 consecutive allo-HSCT patients at First Affiliated Hospital of Soochow University from December 2011 to August 2013. CMV and EBV DNA were regularly monitored by quantitative polymerase chain reaction (PCR) from the engraftment of granuloCyte within one year after… CONTINUE READING
    2 Citations